Supplements
Supplement: Current and Emerging Treatment Approaches Addess Unmet Needs in Glaucoma Care
Sustained-release implants and micro- or minimally invasive glaucoma surgeries (MIGS) are emerging therapies that address key unmet needs in glaucoma treatment. By broadening the spectrum of interventions, these therapies allow glaucoma specialists to consider more measured approaches earlier in disease progression, with a view to delay as well as safeguard the possibility of further invasive surgeries. Drs. Herbert Reitsamer, Andrew Tatham, and Iqbal Ike K. Ahmed discuss how patient compliance impacts glaucoma progression, the role of sustained-release drug delivery and MIGS in alleviating patient treatment burden, the use of MIGS in combination with cataract surgery, and how these therapies can be incorporated into the treatment paradigm.
Tags: glaucoma
Latest Articles
Overcoming Barriers to Presbyopic IOL Uptake
Improving technology, patient and doctor awareness, and reimbursement are keys.
Training in the Digital Era
AI-powered, cloud-based system can effectively improve traineeship, save time, and increase performance.
Treating Myopia, Inside and Outside
Lifestyle changes and ophthalmic interventions play a role in treating paediatric myopia.
The Promises and Pitfalls of AI
While AI shows potential in healthcare, experts agree it requires bias mitigation and human oversight.
Visual Rehabilitation for Keratoconus
Concepts regarding best techniques shift based on learnings from longer follow-up.
Discovering Prodygy and Nirvana
New gene-agnostic treatments for inheritable retinal disease.
Cataract Surgery in Eyes with Corneal Disease
Applying information from preoperative diagnostics guides surgical planning.
Supplement: Integrating Presbyopia-Correction into the Everyday Cataract Practice
ESCRS Research Projects Make a Difference
EPICAT study continues tradition of practice-changing clinical studies.